M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman, Karen Lu, Rita K Schmutzler, Ursula Matulonis, Mark Wickens, Andrew Tutt. Lancet 2010
Times Cited: 977
Times Cited: 977
Joyce F Liu, William T Barry, Michael Birrer, Jung-Min Lee, Ronald J Buckanovich, Gini F Fleming, Bj Rimel, Mary K Buss, Sreenivasa Nattam, Jean Hurteau, Weixiu Luo, Philippa Quy, Christin Whalen, Lisa Obermayer, Hang Lee, Eric P Winer, Elise C Kohn, S Percy Ivy, Ursula A Matulonis. Lancet Oncol 2014
Times Cited: 389
Times Cited: 389
List of shared articles
Times cited
Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma.
Arun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, Valentina Zanfagnin, Amelia M Huehls, Rebecca L Kelly, Husheng Ding, Melissa C Larson, George Vasmatzis, Ann L Oberg,[...]. Cancer Res 2022
Arun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom, Valentina Zanfagnin, Amelia M Huehls, Rebecca L Kelly, Husheng Ding, Melissa C Larson, George Vasmatzis, Ann L Oberg,[...]. Cancer Res 2022
Short-term starvation synergistically enhances cytotoxicity of Niraparib via Akt/mTOR signaling pathway in ovarian cancer therapy.
Wang Zhi, Suting Li, Yuting Wan, Fuwen Wu, Li Hong. Cancer Cell Int 2022
Wang Zhi, Suting Li, Yuting Wan, Fuwen Wu, Li Hong. Cancer Cell Int 2022
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Abigail Tattersall, Neil Ryan, Alison J Wiggans, Ewelina Rogozińska, Jo Morrison. Cochrane Database Syst Rev 2022
Abigail Tattersall, Neil Ryan, Alison J Wiggans, Ewelina Rogozińska, Jo Morrison. Cochrane Database Syst Rev 2022
PARP inhibitors in ovarian cancer: An overview of the practice-changing trials.
Tiffany Foo, Angela George, Susana Banerjee. Genes Chromosomes Cancer 2021
Tiffany Foo, Angela George, Susana Banerjee. Genes Chromosomes Cancer 2021
Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer.
Virginie Mieulet, Camille Garnier, Yann Kieffer, Thomas Guilbert, Fariba Nemati, Elisabetta Marangoni, Gilles Renault, Foucauld Chamming's, Anne Vincent-Salomon, Fatima Mechta-Grigoriou. Sci Rep 2021
Virginie Mieulet, Camille Garnier, Yann Kieffer, Thomas Guilbert, Fariba Nemati, Elisabetta Marangoni, Gilles Renault, Foucauld Chamming's, Anne Vincent-Salomon, Fatima Mechta-Grigoriou. Sci Rep 2021
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, Marianna Sirico, Silvia P Corona, Mario Giuliano, Mariavittoria Locci, Ida Paris, Giovanni Scambia, Sabino De Placido,[...]. Eur J Cancer 2021
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, Marianna Sirico, Silvia P Corona, Mario Giuliano, Mariavittoria Locci, Ida Paris, Giovanni Scambia, Sabino De Placido,[...]. Eur J Cancer 2021
PARP inhibitors: a tsunami of indications in different malignancies.
Gaëlle Haddad, Marie Christelle Saadé, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie. Pharmacogenomics 2020
Gaëlle Haddad, Marie Christelle Saadé, Roland Eid, Fady Gh Haddad, Hampig Raphael Kourie. Pharmacogenomics 2020